Edition:
United States

Nightstar Therapeutics PLC (NITE.OQ)

NITE.OQ on NASDAQ Stock Exchange Global Select Market

14.74USD
18 Jan 2019
Change (% chg)

-- (--)
Prev Close
$14.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
44,586
52-wk High
$28.38
52-wk Low
$9.62

Latest Key Developments (Source: Significant Developments)

Nightstar Therapeutics Q3 Loss Per Share $0.27
Tuesday, 13 Nov 2018 01:00am EST 

Nov 13 (Reuters) - Nightstar Therapeutics PLC ::NIGHTSTAR ANNOUNCES PLANNED INITIATION OF PHASE 2/3 EXPANSION STUDY IN XIRIUS TRIAL FOR NSR-RPGR IN XLRP AND REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.27.Q3 EARNINGS PER SHARE VIEW $-0.40 -- THOMSON REUTERS I/B/E/S.  Full Article

Nightstar Announces Pricing Of Public Offering
Thursday, 27 Sep 2018 09:11pm EDT 

Sept 27 (Reuters) - Nightstar Therapeutics PLC ::NIGHTSTAR ANNOUNCES PRICING OF PUBLIC OFFERING.NIGHTSTAR THERAPEUTICS- PRICED UNDERWRITTEN PUBLIC OFFERING OF 4 MILLION ADS REPRESENTING 4 MILLION SHARES AT A PUBLIC OFFERING PRICE OF $18.00 PER ADS.  Full Article

Nightstar Therapeutics PLC Files For Offering Of Up To 4.0 Mln American Depositary Shares
Tuesday, 25 Sep 2018 04:25pm EDT 

Sept 25 (Reuters) - Nightstar Therapeutics PLC ::NIGHTSTAR THERAPEUTICS PLC FILES FOR OFFERING OF UP TO 4.0 MILLION AMERICAN DEPOSITARY SHARES - SEC FILING.  Full Article

Nightstar Therapeutics announces pricing of initial public offering
Wednesday, 27 Sep 2017 08:14pm EDT 

Sept 27 (Reuters) - Nightstar Therapeutics Ltd :Nightstar announces pricing of initial public offering.Pricing initial public offering of 5.4 million American Depositary Shares at $14 per ADS for total gross proceeds of about $75 million.  Full Article